FDA Public Workshop To Gain Insight Into Profit-Motivated Adulteration
This article was originally published in The Rose Sheet
Executive Summary
FDA plans to hold a public workshop this spring to begin more intensively combating profit-motivated adulteration of regulated products
You may also be interested in...
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture
Updated USP Glycerin Standard Should Prevent Product Adulteration
A revised testing protocol from U.S. Pharmacopeia should help prevent adulterated glycerin, an ingredient in toothpastes, from entering the U.S. supply chain